Global Financial Private Capital’s Emergent Biosolutions EBS Stock Holding History

Global Financial Private Capital’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$317K	Sell	4,010 -58	-1%	-$4.32K	0.02%	219
2020 Q1	$233K	Sell	4,068 -444	-10%	-$25.6K	0.01%	223
2019 Q4	$243K	Sell	4,512 -114	-2%	-$6.18K	0.01%	240
2019 Q3	$242K	Buy	4,626 +419	+10%	+$19.5K	0.01%	239
2019 Q2	$203K	Sell	4,207 -6,237	-60%	-$299K	0.01%	264
2019 Q1	$528K	Buy	10,444 +167	+2%	+$9.85K	0.03%	290
2018 Q4	$609K	Buy	10,277 +3,808	+59%	+$245K	0.03%	239
2018 Q3	$426K	Sell	6,469 -1,306	-17%	-$76.2K	0.02%	405
2018 Q2	$393K	Buy	7,775 +228	+3%	+$11.9K	0.01%	414
2018 Q1	$397K	Buy	+7,547	New	+$376K	0.01%	398

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Global Financial Private Capital's EBS Position: Q2 2020 in Review

Global Financial Private Capital reduced its Emergent Biosolutions (EBS) stake by 1.4% in Q2 2020, selling an estimated $4.32K and leaving 4,010 shares worth $317K. The position accounts for 0.02% of the portfolio, ranked #219.

Global Financial Private Capital first reported a position in EBS in Q1 2018 and has held it in 10 quarters since. The position peaked at $609K in Q4 2018. 299 funds tracked by Wall St. Rank hold EBS as of Q2 2020.

Global Financial Private Capital held 4,010 shares of Emergent Biosolutions worth $317K as of Q2 2020.
Global Financial Private Capital sold 58 Emergent Biosolutions shares in Q2 2020, an estimated $4.32K.
Emergent Biosolutions made up 0.02% of Global Financial Private Capital's portfolio in Q2 2020, its #219 holding.
Global Financial Private Capital first reported a position in Emergent Biosolutions in Q1 2018 and has held it in 10 quarters since.
Global Financial Private Capital's Emergent Biosolutions position peaked at $609K in Q4 2018.
299 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.